Related references
Note: Only part of the references are listed.Mitochondrial Diseases: Hope for the Future
Oliver M. Russell et al.
CELL (2020)
Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies
Rachel M. Bailey et al.
BRAIN RESEARCH (2020)
Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges
Sumit Ghosh et al.
APPLIED BIOSAFETY (2020)
Lifelong reduction in complex IV induces tissue-specific metabolic effects but does not reduce lifespan or healthspan in mice
Sathyaseelan S. Deepa et al.
AGING CELL (2018)
Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy
Rachel M. Bailey et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Gene therapy for neurological disorders: progress and prospects
Benjamin E. Deverman et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome
I. Di Meo et al.
GENE THERAPY (2017)
Leigh syndrome: One disorder, more than 75 monogenic causes
Nicole J. Lake et al.
ANNALS OF NEUROLOGY (2016)
Loss of the smallest subunit of cytochrome c oxidase, COX8A, causes Leigh-like syndrome and epilepsy
Kerstin Hallmann et al.
BRAIN (2016)
Tissue- and species-specific differences in cytochrome c oxidase assembly induced by SURF1 defects
Nikola Kovarova et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
Nathalie Clement et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Complex IV-deficient Surf1-/- mice initiate mitochondrial stress responses
Daniel A. Pulliam et al.
BIOCHEMICAL JOURNAL (2014)
Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
S. J. Gray et al.
GENE THERAPY (2013)
Decreased in vitro mitochondrial function is associated with enhanced brain metabolism, blood flow, and memory in Surf1-deficient mice
Ai-Ling Lin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
SURF1 deficiency: a multi-centre natural history study
Yehani Wedatilake et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Role of Surf1 in heme recruitment for bacterial COX biogenesis
Achim Hannappel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2012)
Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs
T. Federici et al.
GENE THERAPY (2012)
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
Carlo Viscomi et al.
CELL METABOLISM (2011)
Comparison of Adeno-Associated Viral Vector Serotypes for Spinal Cord and Motor Neuron Gene Delivery
Brooke R. Snyder et al.
HUMAN GENE THERAPY (2011)
Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors
Steven J. Gray et al.
HUMAN GENE THERAPY (2011)
Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
Steven J. Gray et al.
MOLECULAR THERAPY (2011)
Surf1, Associated with Leigh Syndrome in Humans, Is a Heme-binding Protein in Bacterial Oxidase Biogenesis
Freya A. Bundschuh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque et al.
MOLECULAR THERAPY (2009)
Isolation of mitochondria from rat brain using Percoll density gradient centrifugation
Neil R. Sims et al.
NATURE PROTOCOLS (2008)
Increased longevity and refractoriness to Ca2+-dependent neurodegeneration in Surf1 knockout mice
Carlotta Dell'Agnello et al.
HUMAN MOLECULAR GENETICS (2007)
Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts
Christian Frezza et al.
NATURE PROTOCOLS (2007)
Constitutive knockout of Surf1 is associated with high embryonic lethality, mitochondrial disease and cytochrome c oxidase deficiency in mice
A Agostino et al.
HUMAN MOLECULAR GENETICS (2003)
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
DM McCarty et al.
GENE THERAPY (2003)
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
DM McCarty et al.
GENE THERAPY (2001)
Share Paper
